BJ Turner

Investor

2 past transactions

RealSeq Biosciences

Seed Round in 2023
RealSeq Biosciences specializes in advanced RNA fragmentomics technology focused on enhancing the detection of diseases to improve diagnosis and treatment. The company's innovative proprietary methods facilitate bias-free small RNA and miRNA next-generation sequencing (NGS) library construction, making their technology particularly valuable in biomarker discovery, liquid biopsy, and single-cell analysis. RealSeq's applications are primarily directed towards cancer and infectious diseases, enabling healthcare providers to enhance patient outcomes through its cutting-edge RNA-based services.

ARwall

Series A in 2019
ARwall Inc., established in 2017 and based in Studio City, California, specializes in developing augmented reality (AR) tools tailored for digital filmmaking. The company's primary product is ARwall FX, an AR display designed for visual effects in films and television. Additionally, ARwall offers AR3D, a tool enabling users to interact with virtual reality and AR experiences on-screen via a virtual window illusion. The company operates a Phase 2 production studio in Los Angeles, serving filmmakers, cinematographers, production designers, and CG technical artists in the area. ARwall provides consulting services and turnkey solutions spanning creative, hardware, software, and immersive XR innovation to creators and filmmakers of all levels.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.